Basit öğe kaydını göster

dc.contributor.authorKeskin, Ahmet
dc.contributor.authorÜnalacak, Murat
dc.contributor.authorBilge, Uğur
dc.contributor.authorYıldız, Pınar
dc.contributor.authorGüler, Seda
dc.contributor.authorSelçuk, Engin Burak
dc.contributor.authorBilgin, Muzaffer
dc.date.accessioned2020-01-27T10:50:39Z
dc.date.available2020-01-27T10:50:39Z
dc.date.issued2015
dc.identifier.issn0366-6999
dc.identifier.urihttps://doi.org/10.4103/0366-6999.171415
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797503/
dc.identifier.urihttp://hdl.handle.net/11655/21872
dc.description.abstractBackground: Studies have reported the presence of sleep disorders in approximately 50–70% of diabetic patients, and these may contribute to poor glycemic control, diabetic neuropathy, and overnight hypoglycemia. The aim of this study was to determine the frequency of sleep disorders in diabetic patients, and to investigate possible relationships between scores of these sleep disorders and obstructive sleep apnea syndrome (OSAS) and diabetic parameters (fasting blood glucose, glycated hemoglobin A1c [HbA1c], and lipid levels). Methods: We used the Berlin questionnaire (BQ) for OSAS, the Epworth Sleepiness Scale (ESS), and the Pittsburgh Sleep Quality Index (PSQI) to determine the frequency of sleep disorders and their possible relationships with fasting blood glucose, HbA1c, and lipid levels. Results: The study included 585 type 2 diabetic patients admitted to family medicine clinics between October and December 2014. Sleep, sleep quality, and sleep scores were used as the dependent variables in the analysis. The ESS scores showed that 54.40% of patients experienced excessive daytime sleepiness, and according to the PSQI, 64.30% experienced poor-quality sleep. The BQ results indicated that 50.20% of patients were at high-risk of OSAS. HbA1c levels correlated significantly with the ESS and PSQI results (r = 0.23, P < 0.001 and r = 0.14, P = 0.001, respectively), and were significantly higher in those with high-risk of OSAS as defined by the BQ (P < 0.001). These results showed that HbA1c levels were related to sleep disorders. Conclusions: Sleep disorders are common in diabetic patients and negatively affect the control of diabetes. Conversely, poor diabetes control is an important factor disturbing sleep quality. Addressing sleep disturbances in patients who have difficulty controlling their blood glucose has dual benefits: Preventing diabetic complications caused by sleep disturbance and improving diabetes control.tr_TR
dc.language.isoentr_TR
dc.publisherWolters Kluwertr_TR
dc.relation.isversionof10.4103/0366-6999.171415tr_TR
dc.rightsinfo:eu-repo/semantics/openAccesstr_TR
dc.subjectHemoglobin A1ctr_TR
dc.subjectObstructive sleep apnea syndrometr_TR
dc.subjectSleep disorderstr_TR
dc.subjectType 2 diabetes mellitustr_TR
dc.subject.lcshAile Sağlığıtr_TR
dc.titleEffects of Sleep Disorders on Hemoglobin A1C Levels In Type 2 Diabetic Patientstr_TR
dc.typeinfo:eu-repo/semantics/articletr_TR
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalChinese Medical Journaltr_TR
dc.contributor.departmentAile Sağlığıtr_TR
dc.identifier.volume128tr_TR
dc.identifier.issue24tr_TR
dc.identifier.startpage3292tr_TR
dc.identifier.endpage3297tr_TR
dc.description.indexWoStr_TR
dc.description.indexScopustr_TR
dc.description.indexPubMedtr_TR
dc.fundingYoktr_TR


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster